|
WO2016019837A1
|
|
Method for preparing intermediates of himbacine analogs
|
|
CN104496979A
|
|
Method for preparing oxazolidinone compound and intermediate thereof
|
|
CN105315282A
|
|
Preparation method of ticagrelor amorphous form
|
|
CN103864683A
|
|
Medicine eutectic of ciprofloxacin and salicylic acid and preparation process thereof
|
|
CN103936837A
|
|
Method used for high-efficient purification of pneumocandins B0
|
|
CN104784699A
|
|
Folate receptor binding ligand-drug conjugate
|
|
CN104250289A
|
|
Method for separating and purifying Pneumocandins B0
|
|
CN104250290A
|
|
Method for separating and purifying caspofungin or its salt
|
|
CN104098571A
|
|
Crystal form of Ticagrelor Brilinta and preparation method thereof
|
|
CN104098572A
|
|
Eutectic form of Ticagrelor Brilinta
|
|
CN103772393A
|
|
Ticagrelor crystal forms and preparation method thereof
|
|
CN104058990A
|
|
Separation analysis method of aliskiren and salts thereof
|
|
CN104045620A
|
|
Preparation method of intermediate of ticagrelor
|
|
CN103130677A
|
|
Preparation method of aliskiren
|
|
CN103908432A
|
|
Ixabepilone albumin freeze-dried composition and preparation method thereof
|
|
CN103848834A
|
|
Method for preparing ticagrelor and intermediate of ticagrelor
|
|
CN103664697A
|
|
Chemical method used for preparing aromatic cyclopropanecarbonitrile and cyclopropylamine
|
|
CN103570774A
|
|
Method for purifying pentose compounds
|
|
CN103182278A
|
|
Membrane dispersion type microchannel reactor
|
|
CN103172533A
|
|
New crystal form of Aliskiren hemifumarate, and preparation method and use thereof
|
